Nemluvio 30 MG
Ended Awarded
- Contract number
- 36C24526N0298
- Awardee
-
Galderma Laboratories, L.P. UEI MNX4XY6QXEL3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $31,800
Award facts
- Contract value 100% obligated
- $31,800.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards $31.8K to Galderma Laboratories, L.P. for the supply of Nemluvio 30 mg, an injectable pharmaceutical product, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is funded by Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs, with performance occurring in Carrollton, Texas. The award employs a firm fixed-price structure with no set-aside designation and an ultimate completion date of February 9, 2026. Galderma Laboratories serves as the prime contractor with no identified subcontractor involvement.
Galderma Laboratories, L.P., a Dallas-based foreign-owned pharmaceutical manufacturer and a child entity within a larger corporate structure, has been a federal contractor since February 2002 and specializes exclusively in supplying injectable pharmaceutical products to the VA healthcare system. This award represents one of ten delivery orders and purchase orders the company received from various VISNs between September 2024 and December 2025, reflecting its established role as a specialized supplier of Nemolizumab and Nemluvio formulations to support VA patient care operations. The short completion timeline typical of these delivery orders underscores the time-sensitive nature of pharmaceutical supply in the VA's distributed healthcare network.
Quick answers
Who was awarded contract 36C24526N0298?
36C24526N0298 was awarded to Galderma Laboratories, L.P. by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 6, 2026.
How much is contract 36C24526N0298 worth?
The government has obligated $31,800 on 36C24526N0298.
Is contract 36C24526N0298 an order under another contract?
Yes. 36C24526N0298 is a delivery order under V797D70255, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0298 competed?
The extent of competition for 36C24526N0298 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award